Relmada Therapeutics Inc (RLMD) — Strategic Asset Allocation Index
Relmada Therapeutics Inc (RLMD) has a Strategic Asset Allocation Index of 0.0% as of March 2021. Strategic assets (PP&E of $452.00 plus long-term investments of $-) total $452.00, measured against net assets of $91.15 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Relmada Therapeutics Inc Strategic Asset Allocation Index (2014–2020)
This chart shows how Relmada Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2020. As of March 2021, the index stands at 0.0%, representing strategic assets of $452.00 against net assets of $91.15 Million USD. Explore cash flow conversion of Relmada Therapeutics Inc to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Relmada Therapeutics Inc (2014–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Relmada Therapeutics Inc from 2014 to 2020, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Relmada Therapeutics Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 0.0% | $1.26K | $1.26K | $- | $105.58 Million | ▼ 0.0 pp |
| 2019 | 0.0% | $5.01K | $5.01K | $- | $115.68 Million | ▼ -0.8 pp |
| 2017 | 0.8% | $12.08K | $12.08K | $- | $1.46 Million | ▼ -4.0 pp |
| 2016 | 4.8% | $340.05K | $2.31K | $337.73K | $7.04 Million | ▼ -1.2 pp |
| 2015 | 6.0% | $531.35K | $531.35K | $- | $8.81 Million | ▲ +5.8 pp |
| 2014 | 0.3% | $23.91K | $23.91K | $- | $8.81 Million | — |